Clinical Trial Update: Study to Evaluate the Efficacy of Two Treatment Schemes With Antivipmyn ® for the Treatment of Snake Bite Envenomation [Phase 4]

View source ↗

Summary

The Phase 4 trial evaluating two Antivipmyn treatment schemes for snakebite envenomation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Snakebite Envenomation

Drugs mentioned

• Antivipmyn

Snippet

Sponsor: Instituto Bioclon S.A. de C.V. | Conditions: Snake Bite | Phase 4 | Status: TERMINATED